eXoZymes, Inc. EXOZ

EXOZ Company Overview

eXoZymes, Inc. (Nasdaq: EXOZ) is a biotechnology and synthetic biology company focused on the development and commercialization of engineered enzyme systems designed to enable sustainable biomanufacturing. The company operates within the broader industrial biotechnology, specialty chemicals, and life sciences sectors, with a business model centered on using engineered enzymes and biocatalytic processes to produce chemicals, ingredients, and other compounds that may be difficult, expensive, or environmentally intensive to manufacture through conventional methods.

The company’s primary revenue and development focus has been associated with its proprietary enzyme engineering and bioprocess platform, which is intended to support scalable production across multiple end markets, including pharmaceuticals, nutrition, agriculture, and specialty materials. eXoZymes evolved from earlier synthetic biology and enzyme engineering initiatives and has positioned itself around cell-free or enzyme-based manufacturing approaches that aim to improve production efficiency, reduce waste, and shorten development timelines compared with traditional fermentation or petrochemical processes. Public disclosures indicate the company has pursued a platform-oriented strategy rather than reliance on a single product line.